Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients

American Journal of Gastroenterology

Volumn 91, Issue 7, 1996, Pages 1395-1399

  Figueroa, Guillermo ^a   Acuña, Raul ^b   Troncoso, Miriam ^b   Portell, Dana P ^b   Toledo, Maria S ^b   Albornoz, Viviana ^b   Vigneaux, Jorge ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH SALICYLATE; METRONIDAZOLE; OMEPRAZOLE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REINFECTION; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; ULCER HEALING;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-ULCER AGENTS; BISMUTH; CHILE; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PENICILLINS; PROSPECTIVE STUDIES; RECURRENCE; SALICYLATES; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 0030040074     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Graham DY, Lew GM, Evans DG, et al. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann Intern Med 1991;115:266-9.
2. Graham DY, Ginger ML, Evans DG, et al. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med 1991;115:266-9.
3. Megraud F, Branssens-Rabe MP, Denis F. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 1989;27:1870-3.
4. Talley N, Noak K. The worldwide prevalence of Helicobacler pylori: Asymptomatic infection and clinical states associated with infection in adults. In: Goodwin CS, Worsley BW, eds: Helicobacter pylori: Biology and clinical practice. Florida: CRS Press, 1993:63-83.
5. Tytgat GNJ, Noach LA, Rauws EAJ. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am 1993;22:127-39.
6. Borody T, Andrews P, Mancuso N, et al. Helicobacler pylori reinfection 4 years post eradication. Lancet 1992;339:1295 (letter).
7. Glupczynski Y, Burette A, De Koster E, et al. Metronidazole resistance for Helicobacter pylori. Lancet 1990;335:976-7.
8. National Institutes of Health Consensus Development Conference Statement. Helicobacter pylori in peptic ulcer disease. February 1994: 7-9.
9. Graham D, Lew G, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
10. Kapadia CR. The acquisition of Helicobacler pylori infection: Good news for western societies? Gastroenterology 1994;107:2-3.
11. Medina E. Las enfermedades digestivas en Chile. Panorama epidemiológico. Rev Med Chile 1988;116:282-8.
12. Figueroa G, Acuña R, Jashes M, et al. Antibodies to H. pylori in colonized patients with gastric symptoms and asymptomatic groups. Rev Med Chile 1990;118:1195-200.
13. Figueroa G, Toledo MS, Acuna R, et al Aislamiento de Campylobacter pyloridis en pacientes con patologías gástricas. Rev Med Chile 1986; 114:618-22.
14. Figueroa G, Troncoso M, Portell DP, et al. Prevalence of immunoglobulin G antibodies to Helicobacter pylori in Chilean individuals. Eur J Clin Microbiol Infect Dis 1993;12:795-7.
15. Giglio M, Hoffenberg P, Becker L, et al. Campylobacter pyloridis: Prevalencia en endoscopias normales, gastritis atrófica y úlcera peptica. Rev Med 1988;116:229-32.
16. Goodwin CS, Marshall BJ, Blincow DE, et al. Prevention of nitroimidazole in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: Clinical in vitro studies. J Clin Pathol 1988;41: 207-10.
17. George LL, Borody TJ, Andrews P, et al. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990;153:145-9.
18. Scialabba A, Vignieri S, Termeni R, et al. Omeprazole therapy modifies the gastric localization of Helicobacter pylori. Am J Gastroenterol 1991;86:1276 (letter).
19. Cutler AF, Schubert T. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 1993; 88:1359-61.
20. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-42.
21. Marshall BJ. Campylobacter pylori infection: Diagnosis and therapy. Med J Aust 1989;151:426-7.
22. Passos MCF, Chausson G, Franco G, et al. Recurrence of Helicobacter pylori infection after successful treatment in a developing country. Gastroenterology 1992;102:51A.
23. Sack RB, Gyr K. Helicobacter pylori in developing world. Lancet 1993;341:1274-5.
24. Thijs JC, Zwet AA Van, Oey HB. Efficacy and side effects of triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993;28:934-8.